NEJM Journal Watch Oncology and Hematology Top Stories of 2017

A perspective on the most important research in the field from the past year

This year, our list of NEJM Journal Watch Oncology and Hematology top stories includes studies on breast, prostate, lung, and urothelial cancer as well as malignant and benign hematology. These summaries underscore our goal of identifying the most clinically relevant studies and highlighting their key findings and implications. We look forward to continuing to bring you concise summaries of the most important research in oncology and hematology during the coming year.

Our oncology and hematology top 10 stories of 2017 are as follows:

Author

William J. Gradishar, MD

Disclosures

Consultant/Advisory BoardLilly; AstraZeneca; Gilead

Grant/Research SupportBreast Cancer Research Foundation

Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment

Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)